NYSE:ABBVBiotechs
What Do AbbVie’s Gains in 2025 Mean After Promising Alzheimer’s Drug Results?
Thinking about what to do with AbbVie stock right now? You are in good company. Whether you already own shares or are just considering a position, it is impossible to ignore how much attention the pharmaceutical giant has been getting lately. AbbVie’s share price has climbed nearly 15% year-to-date, and its performance over the last three and five years has been nothing short of stellar, with total returns surpassing 66% and 168% respectively. Clearly, investors have picked up on something...